{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:24:18Z","timestamp":1790871858536,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00908","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:52:18Z","timestamp":1589248338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008\u20132018"],"prefix":"10.3389","volume":"11","author":[{"given":"Ying","family":"Jian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/jac\/dky088","article-title":"Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.","volume":"73","author":"Antonelli","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/JCM.29.3.533-538.1991","article-title":"Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.","volume":"29","author":"Baker","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program.","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin. Infect. Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0924-8579(09)70562-X","article-title":"Risk factors and management of Gram-positive bacteraemia.","volume":"34","author":"Cervera","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B5","year":"2006","journal-title":"Methods for Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically, M7eA6."},{"key":"B6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/22221751.2019.1595161","article-title":"Decreasing methicillin-resistant Staphylococcus aureus (MRSA) infections is attributable to the disappearance of predominant MRSA ST239 clones, Shanghai, 2008-2017.","volume":"8","author":"Dai","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1128\/JCM.02437-06","article-title":"Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico.","volume":"45","author":"Delgado","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis.","volume":"24","author":"Diaz","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/jcm.01929-15","article-title":"Investigation of linezolid resistance in Staphylococci and Enterococci.","volume":"54","author":"Doern","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"B10","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).","volume":"99","author":"Enright","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1016\/j.ijantimicag.2010.11.005","article-title":"Is vancomycin redundant for serious staphylococcal infection?","volume":"36","author":"Gould","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1699-0463.1985.tb02898.x","article-title":"Consumption of antibiotics in three clinical departments and antimicrobial susceptibility of clinically significant isolates of coagu-lase-negative micrococcaceae.","author":"Hansen","year":"2010","journal-title":"APMIS"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment.","volume":"21","author":"Hassoun","year":"2017","journal-title":"Crit. Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/s0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jinf.2009.11.011","article-title":"Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong.","volume":"60","author":"Ho","year":"2010","journal-title":"J. Infect."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000005060","article-title":"Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality.","volume":"95","author":"Hsieh","year":"2016","journal-title":"Medicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China.","volume":"67","author":"Hu","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices.","volume":"49","author":"Jorgensen","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1001\/jama.2014.6364","article-title":"Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.","volume":"312","author":"Kalil","year":"2014","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1128\/aac.50.4.1156-1163.2006","article-title":"Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.","volume":"50","author":"Kehrenberg","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","first-page":"3974","article-title":"Linezolid vs. vancomycin in treatment of methicillin-resistant Staphylococcus aureus infections: a meta-analysis.","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/nejm199808203390806","article-title":"Staphylococcus aureus infections.","volume":"339","author":"Lowy","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1248\/bpb.b13-00670","article-title":"Linezolid minimum inhibitory concentration (MIC) Creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single japanese center.","volume":"37","author":"Motoyasu","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"B26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2217\/17460913.2.3.323","article-title":"Mechanisms of antibiotic resistance in Staphylococcus aureus.","volume":"2","author":"Pantosti","year":"2007","journal-title":"Future Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3168\/jds.S0022-0302(07)72627-9","article-title":"Relationship between antimicrobial drug usage and antimicrobial susceptibility of gram-positive mastitis pathogens.","volume":"90","author":"Pol","year":"2007","journal-title":"J. Dairy Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1093\/cid\/cit614","article-title":"Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.","volume":"58","author":"Rodvold","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cmi.2016.05.007","article-title":"From MIC creep to MIC decline: Staphylococcus aureus antibiotic susceptibility evolution over the last 4 years.","volume":"22","author":"Ruiz","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1128\/aac.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC Creep) against Methicillin-resistant Staphylococcus aureus isolates collected in Nine U.S. Medical Centers from 2002 to 2006.","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/jac\/dkz097","article-title":"Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.","volume":"74","author":"Sassi","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05.","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.","volume":"28","author":"Tong","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/jac\/dkr280","article-title":"Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns.","volume":"66","author":"van Hal","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1086\/313916","article-title":"Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas.","volume":"31","author":"White","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3969\/j.issn.1672-5433.2012.06.002","article-title":"Regulations for clinical application of antibacterial agents-a guiding principle for the administration of antibacterial agents in medical institutions.","volume":"9","author":"Xiao","year":"2012","journal-title":"China Licensed Pharmacist"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008056.pub3","article-title":"Linezolid versus vancomycin for skin and soft tissue infections.","volume":"1","author":"Yue","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a026989","article-title":"Approved glycopeptide antibacterial drugs: mechanism of action and resistance.","volume":"6","author":"Zeng","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ijantimicag.2013.02.014","article-title":"Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006\u20132011 in China.","volume":"41","author":"Zhuo","year":"2013","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00908\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:52:22Z","timestamp":1589248342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00908\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":41,"alternative-id":["10.3389\/fmicb.2020.00908"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00908","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"article-number":"908"}}